U.S. Markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
131.39-0.36 (-0.27%)
At close: 4:01PM EDT
People also watch
PGMRKKOPFEXOM
Full screen
Previous Close131.75
Open131.99
Bid0.00 x 0
Ask0.00 x 0
Day's Range131.27 - 132.39
52 Week Range109.32 - 137.08
Volume4,334,862
Avg. Volume5,302,198
Market Cap352.65B
Beta0.63
PE Ratio (TTM)22.23
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.48%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 days ago

    FDA declines to approve J&J arthritis drug sirukumab

    The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday. The FDA's decision is in keeping with an advisory panel's recommendation in August that the FDA reject the drug. "We are disappointed by this development as we feel the data accumulated to date support the efficacy and safety of sirukumab," said Dr. Newman Yeilding, head of immunology at J&J's Janssen subsidiary.

  • Reuters2 days ago

    U.S. FDA rejects J&J's arthritis drug

    The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company ...

  • Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson
    Motley Fool2 days ago

    Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson

    They enjoy dominant positions in the healthcare and consumer products industries. But which is the better buy for investors today?